EWC Code
Solid wastes containing dangerous substances from pharmaceutical MFSU
EUR-Lex Commission Decision 2000/532/EC — Official Journal L 226, 06/09/2000Have a 07 05 13 stream? See the dossier that replaces the feasibility study.
See the validation dossier120,000 tonnes/year EU veterinary and animal research waste · €180M specialist disposal market
Primary buyers include Hazardous waste treatment.
Get your full stream analysisAnnual Volume (EU)
120,000 tonnes/year EU veterinary and animal research waste
Valorisation Range
€180M specialist disposal market
Primary Route
Incineration (Category 1 ABP processing)
Need verified buyer contacts with location-specific pricing?
Get contacts for EWC 07 05 13EWC 07 05 13 is a specific sub-code under EWC 18 02 — Wastes from research, diagnosis, treatment or prevention of disease involving animals. The classification guidance below applies to this waste stream.
EWC 18 02 covers wastes from research, diagnosis, treatment or prevention of disease involving animals. Parallels 18 01 structure: 18 02 01 (sharps not infectious), 18 02 02* (wastes whose collection and disposal is subject to special requirements to prevent infection), 18 02 03 (non-infectious veterinary waste), 18 02 05* (chemicals containing dangerous substances), 18 02 06 (non-hazardous chemicals), 18 02 07* (cytotoxic and cytostatic medicines), 18 02 08 (non-hazardous medicines).
Animal carcasses from veterinary practices and research facilities are typically managed under Animal By-Products Regulation (ABPR) 1069/2009 rather than EWC classification, unless contaminated with clinical materials. Sharps from livestock farms (syringes, needles for vaccination and treatment) increasingly covered by farm sharps collection schemes.
Research animal carcasses from facilities using Category A biological agents (BSL3/BSL4 pathogens) require autoclaving prior to disposal. Animals exposed to cytotoxic drugs in cancer research carry cytotoxic residue; their excreta and carcasses may require cytotoxic waste management procedures.
Typical Generators
Established valorisation pathways for EWC 07 05 13, ranked by economic value and market depth.
Infectious veterinary waste and animal by-products not suitable for rendering incinerated at licensed Category 1 ABP processing plant under ABPR 1069/2009 or clinical waste incinerator under IED. Both routes provide definitive pathogen destruction.
Non-Category-A veterinary infectious waste autoclaved at licensed treatment facility. Validated decontamination reduces to non-infectious status. Treated solid residues disposed as non-hazardous waste; reduces incineration demand.
Non-infectious animal carcasses and tissues from veterinary practices without infectious status processed at Category 2 or 3 ABP rendering plants. Rendered products (meat and bone meal, fats) used in energy recovery per ABPR permitted uses.
These are the established routes for EWC 07 05 13. Which one your stream qualifies for depends on its composition, volume and region.
See how this gets validatedPrimary & secondary off-takers
Licensed infectious veterinary waste incineration and treatment
Veterinary practices generating clinical waste requiring managed disposal
Abattoirs with veterinary inspection waste streams under ABPR
Animal research laboratories generating controlled laboratory animal waste
Sectors that valorise EWC 07 05 13 as an input material or secondary raw material.
Your solid wastes containing dangerous substances from pharmaceutical mfsu stream is assessed against chemistry, waste classification and proven recovery routes — graded results in your browser in seconds. No call, no commitment.
Recovery tiers only. For numbers that survive a technical review, see the validation dossier.